InsidersTradesSigma
Track the 셀트리온제약 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 셀트리온제약 has published 2 public disclosures. Market capitalisation: €1,898.7bn. The latest transaction was reported on 3 April 2026 (Purchase). Among the most active insiders: 김주범. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations